ID: ALA4764860

Max Phase: Preclinical

Molecular Formula: C17H22ClNO

Molecular Weight: 255.36

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1cccc(C)c1OCC(N)Cc1ccccc1.Cl

Standard InChI:  InChI=1S/C17H21NO.ClH/c1-13-7-6-8-14(2)17(13)19-12-16(18)11-15-9-4-3-5-10-15;/h3-10,16H,11-12,18H2,1-2H3;1H

Standard InChI Key:  OKJGDLRLOAUIBJ-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 255.36

Molecular Weight (Monoisotopic): 255.1623

AlogP: 3.25

#Rotatable Bonds: 5

Polar Surface Area: 35.25

Molecular Species: BASE

HBA: 2

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 2

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 9.29

CX LogP: 4.12

CX LogD: 2.26

Aromatic Rings: 2

Heavy Atoms: 19

QED Weighted: 0.89

Np Likeness Score: -0.37

References

1. Roselli M,Carocci A,Budriesi R,Micucci M,Toma M,Di Cesare Mannelli L,Lovece A,Catalano A,Cavalluzzi MM,Bruno C,De Palma A,Contino M,Perrone MG,Colabufo NA,Chiarini A,Franchini C,Ghelardini C,Habtemariam S,Lentini G.  (2016)  Synthesis, antiarrhythmic activity, and toxicological evaluation of mexiletine analogues.,  121  [PMID:27267000] [10.1016/j.ejmech.2016.05.046]

Source

Source(1):

• Scientific Literature